文献速递MDS 与骨髓增殖性肿瘤

突变钙网蛋白经分泌途径与MPL相互作用并在细胞表面激活

Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface.
PubMed 文献 · Leukemia · 2019-08-28

本研究探讨突变钙网蛋白(CALR)促骨髓增殖性肿瘤(MPN)的分子机制,发现突变CALR聚集于高尔基体,其进入分泌途径及结合N-糖链的能力是经持续激活MPL发挥致癌作用所必需。突变CALR依赖的MPL激活对细胞内蛋白转运阻断不敏感,但去除细胞表面MPL可终止下游激活,且两者在细胞表面相互作用,提示MPL在细胞表面被激活。

要点

  • 突变CALR需进入分泌途径并结合N-糖链才能持续激活MPL。
  • MPL激活发生在到达细胞表面之前,但表面定位对激活不可或缺。
  • 突变CALR与MPL在细胞表面相互作用,支持表面激活模型。

核心结论

  • 突变CALR经分泌途径与MPL相互作用,在细胞表面诱导MPL激活以促进MPN发展。

研究设计与样本

  • 基于PubMed来源的Leukemia研究,探讨突变CALR亚细胞定位及其对致癌特性的重要性。

主要发现

  • 突变CALR聚集于高尔基体,其进入分泌途径和结合N-糖链的能力是经持续激活MPL发挥致癌作用所必需。
  • 突变CALR依赖的MPL激活对细胞内蛋白转运阻断不敏感,提示MPL在到达细胞表面之前被激活。
  • 用胰蛋白酶去除细胞表面MPL可关闭下游激活,表明MPL表面定位对突变CALR依赖的激活是必需的。
  • 突变CALR与MPL在细胞表面相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Studies have shown that mutant calreticulin (CALR) constitutively activates the thrombopoietin (TPO) receptor MPL and thus plays a causal role in the development of myeloproliferative neoplasms (MPNs). To further elucidate the molecular mechanism by which mutant CALR promotes MPN development, we studied the subcellular localization of mutant CALR and its importance for the oncogenic properties of mutant CALR. Here, mutant CALR accumulated in the Golgi apparatus, and its entrance into the secretion pathway and capacity to interact with N-glycan were required for its oncogenic capacity via the constitutive activation of MPL. Mutant CALR-dependent MPL activation was resistant to blockade of intracellular protein trafficking, suggesting that MPL is activated before reaching the cell surface. However, removal of MPL from the cell surface with trypsin shut down downstream activation, implying that the surface localization of MPL is required for mutant CALR-dependent activation. Furthermore, we found that mutant CALR and MPL interact on the cell surface. Based on these findings, we propose a model in which mutant CALR induces MPL activation on the cell surface to promote MPN development.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Masubuchi N, Araki M, Yang Y, et al. Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface. Leukemia. 2019. PMID: 31462733. doi:10.1038/s41375-019-0564-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。